Global Antimicrobial Susceptibility Testing Market Trends, Size, Competitive Analysis and Forecast 2021-2025


Posted January 13, 2022 by swatitiwari_11

The outbreak of COVID-19 has given the global antimicrobial susceptibility testing (AST) market a boost.

 
The outbreak of COVID-19 has given the global antimicrobial susceptibility testing (AST) market a boost. The upcoming report by Fairfield Market Research states that the market will gain momentum in the coming years as high-throughput AST methods are being used to prevalence of infectious diseases remains on the rise. These are being used to understand the ongoing antimicrobial resistance, which is the biggest challenge for healthcare platforms globally. Antimicrobial susceptibility testing (AST) systems are vital for facilitating the assessment of antibiotic susceptibility and antimicrobial resistance (AMR).

Get a PDF Sample Copy of Antimicrobial Susceptibility Testing Market:
https://www.fairfieldmarketresearch.com/report/antimicrobial-susceptibility-testing-market/request-sample


Clinical Diagnostics Leading Application Segment Emerges as Popular Segment Amidst Rising Infections

Initial findings state that clinical diagnostics will lead the way for the market as the segment held a lion’s share in 2020. The high prevalence of infectious diseases has fuelled the demand for use of antimicrobial susceptibility testing for accurate diagnosis. Antibacterial testing became the most popular resistance testing technique system in 2020. This trend is attributable to the stringent guidelines designed specifically to streamline the antimicrobial susceptibility testing process. The growing incidences of infections due to pathogenic bacteria are also expected to contribute to the segment’s expansion.

Growing Antibiotic Resistance Pushes Antimicrobial Susceptibility Testing 

According to the global antibiotic statistics, there has been a 35% increase in the consumption of antibiotics between 2000 and 2010. The World Health Organization (WHO) report states that about 700,000 lives per year are lost due to antibiotic resistance. The organization states that the number could reach 10 million per year by 2050. All of these numbers indicate that antibiotic resistance has become a prevalent cause of death. These factors have pushed end users to deploy antimicrobial susceptibility testing for R&D activities and drug discovery. 

North America to Pave the Way

Analysts anticipate that North America will dominate the global AST market by the end of 2025. This dominance will be the result of improved access and higher adoption of advanced susceptibility testing methods and products. Investments in research and development are also expected to favour regional market growth.

Meanwhile, Asia Pacific is also expected to grow at a rapid pace. The region will thrive as several AST suppliers are focussing on this region. Affordable labour will continue to be the backbone of the production of AST equipment in the region. India and China will fuel this rise in the coming years. Similarly, emerging economies such as Brazil, Russia, and South Africa will also be the focus area for growth as antibiotic consumption remains high in these parts of the world as well. Lack of control on the sale of over-the-counter drugs is expected to be the primary driver for the market, predict analysts.

For More Information of Antimicrobial Susceptibility Testing Market Visit:
https://www.fairfieldmarketresearch.com/report/antimicrobial-susceptibility-testing-market

Some of the key players operating in the global antimicrobial susceptibility testing market are Becton, Danaher Corporation, Dickinson and Company, Bio-Rad Laboratories, Inc., HiMedia Laboratories Pvt. Ltd., Thermo Fisher Scientific Inc., MERLIN Diagnostika GmbH, Accelerate Diagnostics, Inc., Creative Diagnostics, The Merck Group, Synbiosis Ltd., Zhuhai DL Biotech Co., Ltd., BIOANALYSE Tıbbi Malz. San. ve Tic. Ltd. Sti., Liofilchem S.r.l., and Alifax S.r.l. 

About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

Contact:
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com
Email: [email protected]
Follow Us: LinkedIn
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Fairfield Market Research
Country United Kingdom
Categories Business , Editorial , Health
Tags antimicrobial susceptibility testing , antimicrobial susceptibility testing market , antimicrobial susceptibility testing market share , antimicrobial susceptibility testing market trend , global antimicrobial susceptibility testing market
Last Updated January 13, 2022